3653 results for «298»

Filter By

3653 results

TAVI procedural complications - Part 5: vascular complications, coronary issues and more

20 May 2026 – From EuroPCR 2026

This session addresses procedural complications during TAVI, focusing on vascular complications, coronary issues, and rare device-related events. It includes case analyses of aortic dissection, valve infolding, stent dislodgement, and management strategies for complex anatomical challenges.

TAVI procedural complications - Part 5: vascular complications, coronary issues and more

Challenging TAVI access: exploring transfemoral boundaries and mastering alternative access

20 May 2026 – From EuroPCR 2026

This session investigates the boundaries of transfemoral access for TAVI and strategies to safely extend its use. It also provides a comprehensive review of facilitated transfemoral TAVI techniques and explores alternative access options, offering critical insights for managing challenging TAVI cases.

Challenging TAVI access: exploring transfemoral boundaries and mastering alternative access

Tackling calcified lesions with IVUS guidance and optimisation

20 May 2026 – From EuroPCR 2026

This session delves into the critical role of Intravascular Ultrasound (IVUS) in characterizing and managing calcified coronary lesions. Attendees can explore an imaging-guided approach to calcium treatment, including case presentations that demonstrate stent selection and procedural optimization. Emphasis is placed on applying imaging-based optimization metrics to...

Tackling calcified lesions with IVUS guidance and optimisation

TAVI: head-to-head trials

20 May 2026 – From EuroPCR 2026

This session presents head-to-head comparisons of TAVI devices from recent randomized trials and registries. Highlights include three-year outcomes from the SMART trial, two-year data from the LANDMARK trial on contemporary valves, comparisons of intra- and supra-annular self-expanding valves, evaluations in large annuli, the ALLEGRA trial focusing...

TAVI: head-to-head trials

When to best combine guided-directed medical therapy and devices at discharge of acute heart failure

20 May 2026 – From EuroPCR 2026

This session addresses the challenges and strategies in optimizing guided-directed medical therapy for acute heart failure patients, especially those intolerant to up-titration. It also covers the assessment and timing for cardiac resynchronisation therapy (CRT), highlighting the benefits of combining medical therapy and device implantation to improve...

When to best combine guided-directed medical therapy and devices at discharge of acute heart failure

Lost, crushed, fractured: stent complications in real life

20 May 2026 – From EuroPCR 2026

This session addresses real-world challenges of stent complications including loss, crushing, and fracture during PCI. Through case-based discussions, it explores complex scenarios such as stent dislodgement, embolisation, and management strategies when initial plans evolve into complicated realities.

Lost, crushed, fractured: stent complications in real life

Registries and trials in mitral TEER

20 May 2026 – From EuroPCR 2026

This comprehensive session reviews registries and clinical trials in mitral transcatheter edge-to-edge repair (TEER). It includes discussions on novel TEER systems, international consensus on PASCAL implants, anatomical predictors of procedural success, and long-term outcomes including ventricular and atrial remodeling after intervention, as well as emerging therapies...

All you need to know about interventional therapies for pulmonary embolism

20 May 2026 – From EuroPCR 2026

Focused on interventional therapies for pulmonary embolism, this session guides on establishing and sustaining Pulmonary Embolism Response Teams (PERT), refining patient selection for intervention, choosing appropriate technologies, and identifying intraprocedural markers indicating successful treatment outcomes.

All you need to know about interventional therapies for pulmonary embolism

Monotherapy vs. DAPT: striking the balance between ischemia and bleeding

20 May 2026 – From EuroPCR 2026

This session examines the balance between ischemic and bleeding risks by comparing monotherapy regimens and dual antiplatelet therapy (DAPT) following PCI. Key topics include clopidogrel versus aspirin monotherapy, aspirin discontinuation timing after ACS, and the impact of P2Y12 adherence on clinical outcomes in high-risk and oral...

Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection

20 May 2026 – From EuroPCR 2026

This session critically evaluates antithrombotic therapy following TAVI, addressing optimal agents and regimens tailored to patients with and without atrial fibrillation. It also reviews clinical presentations and management of valve thrombosis post-TAVI, using guideline-based approaches and real-world cases to individualize patient care.

Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection

Safe management of assisted PCI : what can go wrong

20 May 2026 – From EuroPCR 2026

Explore the complexities and potential complications associated with assisted PCI in this session. Topics include challenges such as microaxial pump kinks, technical aspects of IMPELLA device deployment, and the management of high-risk PCI cases including patients with prior TAVI, highlighting strategies to mitigate risks during protected...

Pulmonary valve: the next frontier in adult structural interventions

19 May 2026 – From EuroPCR 2026

This session highlights the evolving role of the pulmonary valve in adult structural interventions. It reviews complex transcatheter pulmonary valve replacement (TPVR) cases, strategies for managing challenging right ventricular outflow tract anatomies, and percutaneous solutions for pulmonary artery stenosis and related complications.

Unconventional situations during cardiovascular interventions

20 May 2026 – From EuroPCR 2026

This session addresses unconventional and challenging scenarios encountered during cardiovascular interventions, focusing on managing complications effectively in the cathlab. Through detailed case presentations from Argentina, Chile, and Colombia, it explores innovative approaches to acute aortic valve regurgitation, TAVI complications in bicuspid anatomy, and diagnostic dilemmas in...

Advanced heart failure: left ventricular assist device as bridge to optimise guided-directed medical therapy

21 May 2026 – From EuroPCR 2026

This session explores advanced heart failure management with a focus on guided-directed medical therapy and the role of left ventricular assist devices (LVAD) as a bridge to therapy optimization. It discusses clinical, imaging, and biological parameters indicating LVAD use and highlights devices such as the Impella...

Advanced heart failure: left ventricular assist device as bridge to optimise guided-directed medical therapy

Complex PCI - Best cases from PCR Global Interventional Academy - Part 2

21 May 2026 – From EuroPCR 2026

This session showcases best cases from the PCR Global Interventional Academy focusing on complex PCI scenarios. It addresses challenges such as managing ostial left anterior descending artery lesions, strategies for branch protection, implications of coronary involvement during TAVI, and future directions in complex coronary interventions. The...

New techniques and tips in CTO PCI

19 May 2026 – From EuroPCR 2026

This session presents new techniques and practical tips in chronic total occlusion (CTO) percutaneous coronary intervention (PCI). It covers innovative approaches such as the side-flap technique, simplified antegrade strategies for calcified lesions, and retrograde CTO techniques, providing valuable insights into overcoming challenging occlusions.

Redo TAVI challenges

20 May 2026 – From EuroPCR 2026

Focused on the complexities of redo transcatheter aortic valve implantation (TAVI), this session covers innovative techniques such as jailed-balloon to prevent sinus sequestration, CT-guided emergency valve-in-valve procedures, alternative access routes, and strategies to manage coronary occlusion risks during multiple valve interventions.

Ultra-low contrast techniques to improve the safety and quality of PCI in complex and high-risk patients

14 May 2024 – From EuroPCR 2024

Tune in to this session to discover how reducing reliance on contrast opacification enhances procedural safety and enables more thorough revascularization in complex PCI scenarios. Learn that ultra-low contrast (ULC) PCI encompasses various interventional skills and specialized tools, many already familiar to interventional cardiologists. Embrace a...

Ultra-low contrast techniques to improve the safety and quality of PCI in complex and high-risk patients

Revisiting thrombus aspiration in STEMI with continuous power aspiration system

15 May 2024 – From EuroPCR 2024

Tune into this 2024 session for insights into the latest ESC guidelines, strategies to prevent and treat no reflow, and an examination of trials like TASTE, TAPAS, and TOTAL on coronary thrombus management. Explore also the outcomes of the CHEETAH study, pondering a potential paradigm shift,...

Revisiting thrombus aspiration in STEMI with continuous power aspiration system

Solving challenging PCI with laser atherectomy: the forgotten Swiss knife?

15 May 2024 – From EuroPCR 2024

Watch this session to enhance your understanding of laser atherectomy fundamentals, recognize its role in addressing complex lesions like in-stent restenosis and uncrossable lesions, and acquire tips and techniques for ensuring procedural efficiency and safety.

Solving challenging PCI with laser atherectomy; the forgotten Swiss knife?
Didn’t find what you were looking for?